Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
L Pagano, CG Valentini, S Grammatico… - British journal of …, 2016 - Wiley Online Library
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …
Myeloid sarcoma: extramedullary manifestation of myeloid disorders
C Campidelli, C Agostinelli, R Stitson… - American journal of …, 2009 - academic.oup.com
Myeloid sarcoma (MS), also termed extramedullary acute myeloid leukemia, extramedullary
myeloid tumor, and granulocytic sarcoma or chloroma, is a rare manifestation that is …
myeloid tumor, and granulocytic sarcoma or chloroma, is a rare manifestation that is …
[HTML][HTML] Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
The objective of this study was to evaluate the clinical features, prognostic factors, and
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
Myeloid sarcoma (MS) is a rare neoplasm whose knowledge is largely based on case
reports and/or technically dated contributions. Ninety-two MSs in adulthood with clinical data …
reports and/or technically dated contributions. Ninety-two MSs in adulthood with clinical data …
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients
F Julia, T Petrella, M Beylot‐Barry… - British Journal of …, 2013 - academic.oup.com
Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
J Menezes, F Acquadro, M Wiseman, G Gómez-López… - Leukemia, 2014 - nature.com
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare disease that currently
lacks genomic and genetic biomarkers to assist in its clinical management. We performed …
lacks genomic and genetic biomarkers to assist in its clinical management. We performed …
Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which
usually affects elderly males and presents in the skin with frequent involvement of the bone …
usually affects elderly males and presents in the skin with frequent involvement of the bone …
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial
origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs) …
origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs) …
Blastic plasmacytoid dendritic cell neoplasm
F Facchetti, M Ungari, D Marocolo… - Hematology Meeting …, 2009 - pagepress.org
SESSION I neoplasms, although the pathogenesis may be analogous, with a common
clonal origin in both settings. 24-26 BPDCN is characterized by a diffuse and …
clonal origin in both settings. 24-26 BPDCN is characterized by a diffuse and …
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
T Aoki, R Suzuki, Y Kuwatsuka, S Kako… - Blood, The Journal …, 2015 - ashpublications.org
We sought to clarify the role of high-dose chemotherapy followed by autologous
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …